Stamford, CT -- (SBWIRE) -- 01/31/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Advanced Cell Technology, Inc. (OTCMKTS:ACTC), Mast Therapeutics Inc (NYSEMKT:MSTX), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN, United States Steel Corporation (NYSE:X)
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) opened the session at $0.08, trading in a range of $0.07 - $0.08,. The stock showed a negative performance of -6.25% in the last trading session from its previous close of $0.08 and closed at $0.0750. The stock traded on a volume of 30.34 million shares and the average volume of the stock remained 13.30 million shares. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Has ACTC Found The Bottom and Ready To Move Up? Find Out Here
Mast Therapeutics Inc (NYSEMKT:MSTX) traded 1.88 million shares in the last business day while the average volume of the stock remained 5.84 million shares. The stock showed a positive movement of +3.63% to end at $0.850. The 52 week range of the stock remained $0.40 - $1.10. Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease.
For How Long MSTX’s Gloss will Attract Investors? Find out via this report
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) reported 67.00 million shares were exchanged during the last trade, while the average volume is about 817,566 shares. The stock escalated +20.53% and finished the day at $12.33. The beta of the stock is recorded at 1.23. Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer’s disease.
For How Long PRAN’s Gloss will Attract Investors? Find out via this report
United States Steel Corporation (NYSE:X) shares rose, +2.26 percent from its previous close of $25.65 to close at $26.23. Traded with volume of 8.55 million shares in the prior session and the average volume of the stock remained 7.53 million shares. United States Steel Corporation (U. S. Steel) is an integrated steel producer of flat-rolled and tubular products with production ope. S. Steel is also engaged in other business activities consisting primarily of transportation services (railroad and barge operations) and real estate operations. rations in North America and Europe.
Why Should Investors Buy X After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)